SCHEMBL3714985

SCHEMBL3714985

CC(C)COC(=O)N1CCNC(CO)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.40
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
REN P00797 2/20 0.36
HSD11B1 P28845 1/20 0.36
DGAT2 Q96PD7 1/20 0.35
MEN1 O00255 1/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 1/20 0.34
SCN9A Q15858 3/20 0.34
ITGB2 P05107 1/20 0.34
ICAM1 P05362 1/20 0.34
ITGAL P20701 1/20 0.34
KIT P10721 1/20 0.33
SLC18A2 Q05940 1/20 0.33
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA4 P22748 2/20 0.33
CA9 Q16790 2/20 0.33
GPR119 Q8TDV5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29092031 0.86 RAB9A (0.38) RAB9AJAK2JAK1RENHSD11B1
SCHEMBL28750702 0.85 ALDH1A1 (0.43) REN
SCHEMBL29270907 0.85 ALDH1A1 (0.43) REN
SCHEMBL10416359 0.80 CHRNB2 (0.42) RENSCN9AITGB2ICAM1ITGAL
SCHEMBL30578823 0.79 POLB (0.48) RENSCN9ACA1CA2CA4
SCHEMBL21296102 0.79 POLB (0.48) RENSCN9ACA1CA2CA4
SCHEMBL26741797 0.79 REN (0.40) RENSCN9AITGB2ICAM1ITGAL
SCHEMBL112264 0.78 RAB9A (0.44) RAB9AMEN1HPGDKMT2AKIT
Hydrochloric Acid SCHEMBL27854646 0.78 POLB (0.47) RENSCN9A
SCHEMBL26204816 0.77 CHRNB2 (0.43) RENSCN9AITGB2ICAM1ITGAL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010102663-A1 PIPERAZINE DERIVATIVES FOR USE IN THERAPY GLAXO GROUP LIMITED (GB) 2010-09-16 WO disclosed
EP-1928886-A1 PYRIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS SmithKline Beecham Corporation (US) 2008-06-11 EP disclosed
WO-2007028654-A1 PYRIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS SMITHKLINE BEECHAM CORPORATION (US) 2007-03-15 WO disclosed